Lancet endcap pointer
Latest Bayer Corporation Patents:
- Acaricidal active substance combinations
- Method of calculating and displaying premium freight costs
- Enhanced transfection system
- Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
- Quantitation of enzyme activity using planar waveguides
Description
FIG. 1 is a perspective view of our design, with the endcap shown in phantom lines for illustative purposes only and forms no part of the claimed design;
FIG. 2 is a fragmentary top view of our design, with the endcap shown in phantom lines for illustrative purposes only and forms no part of the claimed design;
FIG. 3 is a fragmentary side view of our design, with the endcap show in phantom lines for illustrative purposes only and forms no part of the claimed design; and,
FIG. 4 is a bottom view thereof.
Referenced Cited
Patent History
Patent number: D393717
Type: Grant
Filed: Mar 21, 1997
Date of Patent: Apr 21, 1998
Assignee: Bayer Corporation (Pittsburgh, PA)
Inventors: Allen Brenneman (Goshen, IN), Gregory Lorch (South Bend, IN), D. Glenn Purcell (Edwardsburg, MI)
Primary Examiner: Doris Clark
Attorney: Roger N. Coe
Application Number: 0/68,537
Type: Grant
Filed: Mar 21, 1997
Date of Patent: Apr 21, 1998
Assignee: Bayer Corporation (Pittsburgh, PA)
Inventors: Allen Brenneman (Goshen, IN), Gregory Lorch (South Bend, IN), D. Glenn Purcell (Edwardsburg, MI)
Primary Examiner: Doris Clark
Attorney: Roger N. Coe
Application Number: 0/68,537
Classifications